Market Data graphic

Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

Blueberries Medical Corp. (Blueberries) is seeking to become a large scale producer of naturally grown premium quality cannabis with its primary operations well situated in the Bogotá savanna in central Colombia. Lead by a specialized team with proprietary expertise in agriculture, genetics, extraction, medicine, pharmacology and marketing, Blueberries has received all licenses required for the cultivation, production, domestic distribution, and international export of CBD (cannabidiol) and THC (tetrahydrocannabinol)-based medical cannabis. Blueberries’ combination of leading scientific expertise, agricultural advantages, and distribution arrangements has positioned the company to become a leading international supplier of naturally grown, processed, and standardized medicinal-grade cannabis oil extracts and related products.

Body and Mind is debt free a multi-state operator in California, Nevada, Ohio and Arkansas. The Company invests in high quality medical and recreational cannabis cultivation, production/ manufacturing and retail. 

BaM products include dried flower, edibles, extracts and oils as well as GPEN Gio cartridges . BaM cannabis strains have won numerous awards including the 2019 Las Vegas Weekly Bud Bracket, Las Vegas Hempfest Cup 2016, High Times Top Ten, the NorCal Secret Cup and the Emerald Cup.

BaM continues to expand operations in California, Nevada, Arkansas, Ohio and is dedicated to increasing shareholder value by focusing time and resources on improving operational efficiencies, facility expansions, state licensing opportunities as well as mergers and acquisitions.

Please visit www.bamcannabis.com for more information.

Bright Minds is a pre-clinical biosciences company with a portfolio of compounds designed to precisely target abnormalities in neurocircuitry that lead to dysfunctional behaviors. Bright Minds is focused on developing targeted therapies with the potential to improve the treatment of mental health and neurological disorders through the use of serotonergic compounds leveraging its world class scientific and drug development expertise to bring forward the next generation of safe and efficacious neuropsychiatry drugs into the clinic. Bright Minds drugs extenuate the therapeutic aspects of psychedelic and other serotonergic compounds while minimizing the side effects thereby creating superior drugs to first generation compounds, such as psilocybin. Bright Minds was selected to participate in two National Institutes of Health (“NIH”) Programs. These NIH collaborations are evaluating Bright Minds serotonin agonists for therapeutic potential in pain and in epilepsy.

BYND Cannasoft Enterprises Inc. (“BYND”) owns and markets a proprietary customer relationship management (CRM) software product, known as “Benefit CRM” which enables small and medium-sized businesses to optimize their day-to-day business activities. BYND  plans to roll out the next generation of its Benefit CRM software, which will be cloud based in the next few months.

BYND has recently begun development of an entirely new, innovative CRM platform, designed specifically to serve the needs of the medical cannabis industry.   BYND has also obtained a primary growing license for growing medical cannabis in Israel and hopes to begin construction of a farm facility in late Q2 or Q3 of this year. Once the cannabis farm becomes operational, Cannasoft intends to work with strategic partners to develop and market new, proprietary cannabis infused products for sale throughout Israel and for export.

C21 Investments Inc. is a vertically integrated cannabis company with newly acquired operations in Nevada and Oregon, U.S.A.  C21’s strategy is to acquire existing cannabis operations in the U.S.A. and globally, with experienced management teams in place.  C21’s focus is to expand where it can wholly own indoor/outdoor cultivation operations, processing/extraction facilities, bakeries, branded products, and retail dispensaries with a large distribution network.

The Camarico Investment Group Ltd. is an innovative investment issuer engaged in the integrated development, acquisition and partnership of intellectual property, assets and portfolio interests.

Canada House Wellness Group Inc. is the parent company of Abba Medix Corp., a Licensed Producer in Pickering, Ontario that produces high quality medical grade cannabis; Canada House Clinics Inc., clinics across the country that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from common to complex medical conditions; and Knalysis Technologies, a provider of fully customizable, cloud-based software that links physician, provider, and patient to data that supports treatment with medical cannabis.

Canada House Wellness Group’s goal is to become the leading cultivator of premium craft cannabis and provider of cannabinoid therapy, targeting the medical cannabis markets globally. Please visit www.canadahouse.ca.

 

CanaFarma Hemp is a full-service company operating in the hemp industry offering a full range of hemp-related products and services. These products and services include growing top-quality hemp, providing hemp-processing services, and offering hemp-based products to consumers utilizing a direct-to-consumer marketing approach.

Investor Note: In addition to the 195,606,145 common shares that are listed and trading, there are 5,700,000 reserved for issuance pursuant to the conversion rights attached to the Proportionate Voting Shares that are issued and outstanding but not listed. The total number of issued shares assuming all are converted into the listed class would be 201,306,145.

The issuer is a science and technology health and wellness company that encompasses plant based, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) verticals. 

Contact The Team

How can we help you?

Contact the CSE team to find out more.

Advertisement

Publicité

Latest CSE News

Upcoming Events

Advertisement

Publicité